ContractDevelopment Agreement • November 10th, 2021 • Dare Bioscience, Inc. • Pharmaceutical preparations • District of Columbia
CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [**] INDICATES THAT INFORMATION HAS BEEN EXCLUDED.
Second Amendment to License AgreementLicense Agreement • November 10th, 2021 • Dare Bioscience, Inc. • Pharmaceutical preparations
This Second Amendment to License Agreement (“Amendment”) is effective as of September 21, 2021 (the “Second Amendment Date”) and is made by and among Daré Bioscience, Inc., a Delaware corporation (“Daré”), and TriLogic Pharma, LLC, a Delaware limited liability company (“TriLogic”), and MilanaPharm LLC, a Delaware limited liability company (“MilanaPharm,” and individually and collectively with Trilogic each a “Licensor” and together “Licensors”). Licensors and Daré are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
